CD19 CAR mRNA (Human) expresses CAR protein that specifically targets human CD19. It triggers transitory expression of CAR, allowing T cells to be targeted without permanent genetic modification. The product targets CD19, a transmembrane glycoprotein primarily expressed on B lymphocytes and important in B cell activation. It can be studied in cancer research such as lymphoma and leukemia.
- Expresses CAR protein specifically targeting human CD19.
- Triggers transitory expression of CAR, enabling T cell targeting without permanent genetic modification.
- Can be studied in cancer research, including lymphoma and leukemia.